|
Market Closed -
Bombay S.E.
06:02:25 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 2,363.75 INR | -1.87% |
|
+2.88% | +48.48% |
| 07-30 | Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-30 | Hester Biosciences Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 20.11B 213M 183M 172M 157M 294M 295M 2.04B 788M 10.3B 798M 781M 32.8B | P/E 2025 |
38.8x | P/E 2026 | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.99B 233M 200M 188M 172M 321M 322M 2.23B 862M 11.26B 873M 854M 35.87B | EV / Sales 2025 |
4.11x | EV / Sales 2026 | 3.78x |
| Free-Float |
31.22% | Yield 2025 |
0.56% | Yield 2026 | 0.87% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| HESTERBIO | Delayed | |
NSE India S.E.
| HESTERBIO | Delayed |
Last Transcript : Hester Biosciences Limited
| 1 day | -1.87% | ||
| 1 week | +2.88% | ||
| Current month | +4.62% | ||
| 1 month | -3.54% | ||
| 3 months | +20.33% | ||
| 6 months | +59.20% | ||
| Current year | +48.48% |
| 1 week | 2,152 |  | 2,524.9 |
| 1 month | 2,152 | | 2,532 |
| Current year | 1,250.95 | | 2,669 |
| 1 year | 1,250.95 | | 2,669 |
| 3 years | 1,246.75 | | 3,375.45 |
| 5 years | 1,246.75 | | 3,375.45 |
| 10 years | 666 | | 3,375.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 1987-04-28 | |
Ashish Desai
DFI | Director of Finance/CFO | - | 2025-11-19 |
Vinod Mali
CMP | Compliance Officer | - | 2018-05-13 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 2005-04-20 | |
| Director/Board Member | 64 | 1987-04-28 | |
| Director/Board Member | 61 | 1987-04-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.87% | +2.88% | +11.18% | +33.81% | 217M | |
| -0.63% | -1.98% | -50.55% | -59.43% | 31.33B | |
| +0.33% | +1.62% | +32.94% | +104.68% | 12.24B | |
| +0.58% | -2.27% | -11.86% | +4.11% | 3.93B | |
| -1.57% | -2.64% | -3.38% | +17.60% | 3.11B | |
| 0.00% | -2.84% | +50.55% | +30.99% | 2B | |
| -0.44% | -2.85% | +10.14% | +13.67% | 1.89B | |
| -0.86% | +1.54% | -3.04% | +196.28% | 1.55B | |
| +2.77% | +5.09% | -15.95% | -1.36% | 1.2B | |
| +2.03% | +2.18% | -5.38% | -39.57% | 1.05B | |
| Average | +0.11% | +0.27% | +1.46% | +30.08% | 5.85B | |
| Weighted average by Cap. | -0.24% | -0.91% | -19.56% | -2.61% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.12B 33.04M 28.41M 26.72M 24.4M 45.63M 45.77M 317M 122M 1.6B 124M 121M 5.1B | 3.34B 35.33M 30.38M 28.58M 26.09M 48.79M 48.94M 339M 131M 1.71B 133M 130M 5.45B |
| Net income | 275M 2.91M 2.5M 2.35M 2.15M 4.01M 4.03M 27.87M 10.77M 141M 10.92M 10.68M 448M | 556M 5.88M 5.06M 4.76M 4.34M 8.12M 8.15M 56.42M 21.81M 285M 22.09M 21.61M 908M |
| Net Debt | 2.16B 22.88M 19.68M 18.51M 16.89M 31.6M 31.7M 219M 84.82M 1.11B 85.93M 84.05M 3.53B | 1.88B 19.91M 17.12M 16.1M 14.7M 27.49M 27.58M 191M 73.79M 964M 74.75M 73.12M 3.07B |
Employees
483
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-07 | ₹2,363.75 | -1.87% | 538 |
| 26-09-04 | ₹2,408.70 | +9.84% | 2,851 |
| 26-09-03 | ₹2,192.85 | +0.49% | 279 |
| 26-09-02 | ₹2,182.15 | -1.58% | 256 |
| 26-09-01 | ₹2,217.10 | -1.87% | 237 |
- Stock Market
- Stocks
- HESTERBIO Stock
Select your edition
All financial news and data tailored to specific country editions
